Morgan Stanley Passage Bio, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Passage Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 812,442 shares of PASG stock, worth $422,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares

812,442

Previous 13,442 5944.06%

Holding current value

$422,469

Previous $9,000 5044.44%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.47 - $1.13 $375,530 - $902,869	799,000 Added 5944.06%	812,442 $463,000
Q2 2024 Oct 17, 2024	SELL	$0.79 - $1.58 $312 - $624	-395 Reduced 2.85%	13,442 $10,000
Q2 2024 Aug 14, 2024	SELL	$0.79 - $1.58 $312 - $624	-395 Reduced 2.85%	13,442 $10,000
Q1 2024 Oct 17, 2024	BUY	$0.86 - $1.73 $339 - $683	395 Added 2.94%	13,837 $18,000
Q4 2023 Aug 16, 2024	BUY	$0.6 - $1.01 $237 - $398	395 Added 2.94%	13,837 $13,000
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.01 $97,849 - $164,713	-163,083 Reduced 92.18%	13,837 $13,000
Q3 2023 Nov 15, 2023	BUY	$0.66 - $1.01 $43,374 - $66,376	65,719 Added 59.1%	176,920 $116,000
Q2 2023 Aug 14, 2023	SELL	$0.82 - $1.19 $131,176 - $190,365	-159,971 Reduced 58.99%	111,201 $104,000
Q1 2023 May 15, 2023	BUY	$0.96 - $1.88 $224,454 - $439,557	233,807 Added 625.74%	271,172 $260,000
Q4 2022 Feb 14, 2023	SELL	$1.06 - $1.48 $492,994 - $688,331	-465,089 Reduced 92.56%	37,365 $51,000
Q3 2022 Nov 14, 2022	SELL	$1.22 - $2.48 $669,185 - $1.36 Million	-548,513 Reduced 52.19%	502,454 $629,000
Q2 2022 Oct 27, 2022	BUY	$1.63 - $3.46 $631,704 - $1.34 Million	387,549 Added 58.42%	1,050,967 $2.48 Million
Q2 2022 Aug 15, 2022	BUY	$1.63 - $3.46 $631,704 - $1.34 Million	387,549 Added 58.42%	1,050,967 $2.48 Million
Q1 2022 Oct 27, 2022	SELL	$2.66 - $6.49 $1.03 Million - $2.52 Million	-387,549 Reduced 36.88%	663,418 $2.06 Million
Q1 2022 May 13, 2022	SELL	$2.66 - $6.49 $2.36 Million - $5.77 Million	-888,686 Reduced 57.26%	663,418 $2.06 Million
Q4 2021 Feb 14, 2022	BUY	$6.24 - $10.2 $2.55 Million - $4.17 Million	408,662 Added 35.74%	1,552,104 $9.86 Million
Q3 2021 Nov 15, 2021	BUY	$9.73 - $15.52 $11.1 Million - $17.7 Million	1,143,442 New	1,143,442 $11.4 Million

Others Institutions Holding PASG

# of Institutions

Shares Held

37.7M

Call Options Held

10.5K

Put Options Held

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $28.3M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account